Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.089,91
-0,84%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rigel Pharmaceuticals Inc (RIGL) Rigel Pharmaceuticals Inc (RIGL) Notizie

Rigel Pharmaceuticals Inc

RIGL
1,04
-0,03 (-2,80%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202414:05PRNUSRigel Announces Conference Call and Webcast to Report First..
10/4/202422:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/4/202414:05PRNUSRigel Announces Publication of Data on REZLIDHIA®..
12/3/202413:05PRNUSRigel Pharmaceuticals Announces Appointment of Lisa..
05/3/202422:10EDGAR2Form 8-K - Current report
05/3/202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:01PRNUSRigel Reports Fourth Quarter and Full Year 2023 Financial..
02/3/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202414:05PRNUSRigel Announces Conference Call and Webcast to Report Fourth..
22/2/202414:00EDGAR2Form 8-K - Current report
22/2/202413:50PRNUSRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
14/2/202420:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:05PRNUSRigel Pharmaceuticals Provides Business Update
05/1/202422:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/1/202414:05PRNUSRigel Announces Collaboration with CONNECT to Conduct a..
03/1/202414:05PRNUSRigel to Present at the 42nd Annual J.P. Morgan Healthcare..
08/12/202314:05PRNUSRigel Pharmaceuticals and MD Anderson Announce Strategic..
30/11/202312:04EDGAR2Form 8-K - Current report
07/11/202322:16EDGAR2Form 8-K - Current report
07/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:01PRNUSRigel Reports Third Quarter 2023 Financial Results and..
06/11/202314:05PRNUSRigel to Present at the Jefferies London Healthcare..
02/11/202314:27PRNUSRigel Announces Poster Presentations at the 65th American..
31/10/202313:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
11/10/202314:05PRNUSRigel Announces Presentation at the Upcoming IDWeek 2023
06/10/202322:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
20/9/202314:05PRNUSRigel to Present at the 2023 Cantor Global Healthcare..
30/8/202314:05PRNUSRigel to Participate in Upcoming September Investor..
01/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/8/202322:15EDGAR2Form 8-K - Current report
01/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:01PRNUSRigel Reports Second Quarter 2023 Financial Results and..
25/7/202314:00PRNUSRigel Announces Conference Call and Webcast to Report Second..
13/7/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,07 Min: 1,04 Max: 1,1096
Chiusura: 1,07

La tua Cronologia

NASDAQ
RIGL
Rigel Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network